Skip to main content
logo
Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.40
-0.80 (-7.84%)
Jun 1, 2026, 1:05 PM EDT - Market open

Kura Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
71.6467.4853.88---
Revenue Growth (YoY)
5.37%25.24%----
Cost of Revenue
0.320.06----
Gross Profit
71.3267.4353.88---
Selling, General & Admin
128.7119.9877.1150.5747.0546.54
Research & Development
260.36251.07169.97115.2492.8184.72
Total Operating Expenses
389.07371.06247.08165.8139.87131.26
Operating Income
-317.75-303.63-193.2-165.8-139.87-131.26
Interest Income
24.7226.7722.8514.724.251.21
Interest Expense
-1.47-1.51-1.62-1.55-0.23-0.41
Other Non-Operating Income (Expense)
5.34-----
Total Non-Operating Income (Expense)
28.625.2621.2313.174.030.79
Pretax Income
-294.49-278.37-171.97-152.63-135.84-130.47
Provision for Income Taxes
0.080.32.02---
Net Income
-294.57-278.67-173.98-152.63-135.84-130.47
Net Income to Common
-294.57-278.67-173.98-152.63-135.84-130.47
Shares Outstanding (Basic)
888886736766
Shares Outstanding (Diluted)
888886736766
Shares Change (YoY)
1.08%1.76%17.66%9.31%0.96%25.01%
EPS (Basic)
-3.35-3.18-2.02-2.08-2.03-1.97
EPS (Diluted)
-3.35-3.18-2.02-2.08-2.03-1.97
Shares Outstanding
88.7687.8678.2374.3568.3166.57
Free Cash Flow
-84.46-70.7133.85-124.99-110.69-105.7
Free Cash Flow Per Share
-0.96-0.811.55-1.71-1.65-1.59
Gross Margin
99.55%99.92%100.00%---
Operating Margin
-443.54%-449.94%-358.54%---
Profit Margin
-411.19%-412.95%-322.89%---
FCF Margin
-117.89%-104.76%248.40%---
EBITDA
-316.6-302.6-192.35-164.96-139.11-130.7
EBITDA Margin
-441.94%-448.41%-356.97%---
EBIT
-317.75-303.63-193.2-165.8-139.87-131.26
EBIT Margin
-443.54%-449.94%-358.54%---
Effective Tax Rate
-0.03%-0.11%-1.17%0.00%0.00%0.00%
SEC Filings: 10-K · 10-Q